The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s economy. This confidence—or lack thereof—is defined by the degree of optimism within key business indicators.

These indicators include:

  • Capital Markets
  • Deal Landscape
  • Clinical Development
  • Regulatory Affairs
  • Commercialization
  • Business Model and Workforce

Measuring confidence through these six indicators over time will demonstrate an ebb and flow of market dynamics and confidence in the future success of companies and growth in the overall market.

The Biopharma CEO Confidence Index will be issued on a quarterly basis. Kineticos expects to have results from the first index published by October 15, 2015.

The Biopharma CEO Confidence Index is a partnership between Kineticos, Demy-Colton Life Science Advisors, and Ipsos.

purple-with-tagline Ipsos Healthcare Demy Colton Logo